News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sinopharm, Fosun Pharma, China Medicine Corporation Join to Form $157 Million PE Fund


6/26/2012 2:22:26 PM

by Richard Daverman, PhD

June 26, 2012 -- A group of China’s biggest pharma companies have banded together to form a Private Equity Fund that will total 1 billion RMB ($157 million). Sinopharm Capital, a subsidiary of the drug distributing giant Sinopharm, is the General Partner. Limited Partners include Sinopharm’s parent CNPGC, Fosun Pharma and China Meheco. The fund can invest in several sectors of the healthcare industry, including medical treatment, service, manufacturing, distribution, and R&D. More details....

Stock Symbols: (HK: 1099) (SHA: 600196) (SHA: 600056)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES